Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ferrinject versus oral ferrous sulfate for iron deficiency without anaemia in inflammatory bowel disease
ACTRN12617000586314Phase 4Not yet recruiting
- Sponsor
- Dr Stephen Inns
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Intravenous Ferrinject with Oral ferrous sulfate (2 arms). Primary endpoint: Change in quality of health scores. Planned start May 2017; status: not yet recruiting.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12617000586314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000586314.